These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26826186)

  • 1. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
    Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
    J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.
    Edimo WE; Ramos AR; Ghosh S; Vanderwinden JM; Erneux C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):508-514. PubMed ID: 27246739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
    Ramos AR; Elong Edimo W; Erneux C
    Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.
    Ramos AR; Ghosh S; Dedobbeleer M; Robe PA; Rogister B; Erneux C
    FEBS J; 2019 Mar; 286(6):1120-1135. PubMed ID: 30695232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
    Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
    Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells.
    Ghosh S; Scozzaro S; Ramos AR; Delcambre S; Chevalier C; Krejci P; Erneux C
    J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30012834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
    Elong Edimo W; Vanderwinden JM; Erneux C
    Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.
    Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C
    Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
    Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
    Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRSp53 is a novel interactor of SHIP2: A role of the actin binding protein Mena in their cellular localization in breast cancer cells.
    Antoine M; Vandenbroere I; Ghosh S; Erneux C; Pirson I
    Cell Signal; 2020 Sep; 73():109692. PubMed ID: 32535200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
    Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
    Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2.
    Le Coq J; López Navajas P; Rodrigo Martin B; Alfonso C; Lietha D
    FASEB J; 2021 Aug; 35(8):e21815. PubMed ID: 34314064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
    Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated SHIP2 on Y1135 localizes at focal adhesions and at the mitotic spindle in cancer cell lines.
    Deneubourg L; Elong Edimo W; Moreau C; Vanderwinden JM; Erneux C
    Cell Signal; 2014 Jun; 26(6):1193-203. PubMed ID: 24561238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation.
    Elong Edimo W; Schurmans S; Roger PP; Erneux C
    Adv Biol Regul; 2014 Jan; 54():142-51. PubMed ID: 24091101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
    Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
    Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating the activation of ERM proteins.
    Sayyed SG; Jouret F; Vermeersch M; Pérez-Morga D; Schurmans S
    Kidney Int; 2017 Jul; 92(1):125-139. PubMed ID: 28302370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.